Loading…
Vitamin D deficiency: What does it mean for chronic obstructive pulmonary disease (COPD)? a compherensive review for pulmonologists
Objectives Vitamin D deficiency and Chronic Obstructive Pulmonary Disease (COPD) are both under‐recognized health problems, world‐wide. Although Vitamin D has long been known for calcemic effects it also has less known noncalcemic effects. Recent data have shown that Vitamin D deficiency is highly p...
Saved in:
Published in: | The clinical respiratory journal 2018-02, Vol.12 (2), p.382-397 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objectives
Vitamin D deficiency and Chronic Obstructive Pulmonary Disease (COPD) are both under‐recognized health problems, world‐wide. Although Vitamin D has long been known for calcemic effects it also has less known noncalcemic effects. Recent data have shown that Vitamin D deficiency is highly prevalent in patients with COPD and correlates with forced expiratory volume in one second (FEV1) and FEV1 decline. The objective of this work was to review the current literature on vitamin D deficiency in relation with COPD.
Data source
A literature search, using the words “vitamin D” and “COPD”, was undertaken in Pubmed database.
Results
The noncalcemic effects of vitamin D relating with COPD may be summarised as increasing antimicrobial peptide production, regulation of inflammatory response and airway remodelling. Vitamin D inhibits the production of several proinflammatory cytokines and leads to suppression Th1 and Th17 responses which may be involved in the pathogenesis of COPD. Vitamin D insufficiency may also contribute to chronic respiratory infections and airway colonization so returning vitamin D concentrations to an optimal range in patients with COPD might reduce bacterial load and concomitant exacerbations.Vitamin D is also important for COPD‐related comorbodities such as osteoporosis, muscle weakness and cardiovascular diseases. Data about the effect of Vitamin D supplementation on those comorbidities in relation with COPD are been scarce.
Conclusion
Improving the blood level of Vitamin D into the desired range may have a beneficial effect bones and muscles, but more studies are needed to test to test that hypothesis. |
---|---|
ISSN: | 1752-6981 1752-699X |
DOI: | 10.1111/crj.12588 |